Clinically-guided treatments and continuous support from Klinic will significantly impact your path to achieving a healthier lifestyle
Retatrutide is investigational and meets neither requirement
Mounjaro : Brand name tirzepatide FDA-approved for diabetes, but widely used off-label for weight loss due to its powerful dual GIP/GLP-1 mechanism
"Broader access to these medicines is critical, which is why Lilly is committed to working with healthcare, government and industry partners to ensure people who may benefit from Zepbound can access it," said Mike Mason, executive vice president and president of Eli Lilly Diabetes and Obesity, in a statement
From medically supervised treatments to nutritional guidance and sustainable habit-building recommendations, we aim to provide weight loss solutions that are both safe and effective
Patients who have recently started taking a GLP-1 receptor agonist may be at greater risk of delayed gastric emptying than those who have been taking one of these medications for a longer period